Related Experiment Video
Updated: Jun 28, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Primary drug resistance to anti-tuberculous drugs in Karachi
Arshad Javaid1, Nadim Rizvi, Mosavir Ansari
1Department of Pulmonology, Postgraduate Medical Institute, Peshawar. arshadj343@hotmail.com
Objective:
To assess the frequency of primary drug resistance among newly diagnosed tuberculosis cases in Karachi.
Study Design:
Cross-sectional study.
Place And Duration Of Study:
Multicentric study involving various TB clinics and treatment centres of Karachi between April to December 2005.
Methodology:
The frequency of drug resistance among new TB patients was evaluated using a non-probability convenient sampling methodology. Sputum sample was obtained from 140 newly diagnosed sputum smear-positive patients of pulmonary tuberculosis from various centres of Karachi. Sensitivities were performed by proportion method.
Results:
Fifteen (11.5%) samples in 130 eligible patients showed primary resistance to one or more drugs. Ten (7.6%) of the isolates tested were resistant to a single drug, none were resistant to 2 drugs, 4 (3.0%) to 3 drugs and 1 (0.76%) to 4 drugs while 1 (0.76%) to all 5 first line agents. Resistance to streptomycin (10 microg/ml) was seen in 8 (6.1%), isoniazid (1microg/ml) in 12 (9.2%), Rifampicin (5 microg/ml) in 4 (3.0%), ethambutol (10 microg/ml) in 1 (0.76%) and pyrazinamide in 6 (4.6%) samples. Primary Multi-Drug Resistance (PMDR) was found in 2 (1.5%) patients. (Isoniazid 1 microg/ml, rifampicin 5 microg/ml with or without other drugs).
Conclusion:
In the studied patients, primary drug resistance to at least one anti-tuberculosis drug was 11.5%. It requires an efficiently working anti-tuberculosis programme to prevent escalation including resistance.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Development of Antibiotic Resistance
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Treatment Resistant Cancers
